ArticleDiabetes, obesity & metabolism2026
Associations of Semaglutide With Skeletal Outcomes in People With Obesity, With and Without Type 2 Diabetes: A Target Trial Emulation.
Yu-Nan Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.